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Background: A net-based, decision support system for diagnostic assessment and management of psychiatric
disorders, developed as part of a telepsychiatry service, which aims to deliver mental health care to underserved
population of remote areas in India is described. This paper presents the development and preliminary results of
diagnostic validation of the application, intended for use among adult patients. The bilingual (English and Hindi)
diagnostic tool consists of a core diagnostic section comprising a screening sub-module and criteria-based diagnostic
sub-modules for 18 adult psychiatric disorders, and additional sections covering background information. The
diagnostic tool of the application was examined among 100 consecutive consenting adult outpatients, by comparing
it with detailed semi-structured clinical assessments led by a consultant psychiatrist, on accuracy of diagnoses
generated, and examining the feasibility of its use.
Results: The screening sub-module had high sensitivity and high specificity, low positive predictive values, but high
negative predictive values for most disorders. For the diagnostic sub-modules, there was moderate (kappa = 0.4-0.6),
to substantial agreement (kappa > 0.6) between diagnoses generated by the tool and consultants’ diagnoses, for all
the disorders except dysthymia. Sensitivity was high barring a few disorders. Specificity was high for all the disorders,
positive predictive values were acceptable to high for most disorders, and negative predictive values were consistently
high. Completion rate was 100%; average time taken was five minutes for screening alone, and 30 minutes for
complete assessment with screening and criteria-based evaluation. A majority of the patients, their relatives, and
interviewers were satisfied with the interview.
Conclusions: The preliminary results indicated that despite some limitations, the new diagnostic system was
reasonably comprehensive, time-efficient and feasible, with an acceptable level of diagnostic accuracy. Hence, it
appeared to be suitable for use as a telepsychiatric application.
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Mental disorders are highly prevalent and equally dis-
abling in India as in the rest of the world [1,2], and as in
other low-income countries, most people suffering from
mental disorders continue to receive inadequate treat-
ment [3]. Existing discrepancies between resources and
need, urban and rural services, and primary, secondary
and tertiary care, lead to what has been referred to as
the ‘mental health gap’ [4]. Efforts are already underway
in India to reduce the ‘mental health gap’ under the* Correspondence: savita.pgi@gmail.com
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strengthening existing resources, developing new ones
and enhancing manpower [4,6]. However, these measures
are highly resource intensive, and a long gestation period
is expected before they begin to take effect. Telepsychia-
try, the use of information and communication technolo-
gies to provide or support clinical psychiatric care from a
distance, has been proposed as an alternative strategy [7].
Telepsychiatric programmes, which are being increasingly
used in developed nations usually follow different ap-
proaches such as direct patient management though
video-conferencing, consultation models, or collaborative-
care models [8,9]. However, in developing countries like
India, such models are difficult to implement, because ofal Ltd. This is an Open Access article distributed under the terms of the Creative
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proach involving development of software packages with
codified medical knowledge and logical decision support
systems to aid assessment, diagnosis and management of
psychiatric disorders could be a logical alternative [10].
With the broader aims of codifying medical knowledge,
and providing an internet-based decision support system
for diagnosis and treatment of psychiatric disorders, a
pilot telepsychiatric project is underway at the department
of psychiatry of the Postgraduate Institute of Medical
Education and Research (PGIMER), Chandigarh, India.
The department is the nodal centre of this service, with
three peripheral sites located in the adjoining hill states of
north-India. Right from its onset, this telepsychiatric
project has followed a different model of training and
enabling non-specialist (i.e., general physicians and para-
professionals) personnel at remote sites to diagnose and
treat mental illnesses on their own, with minimal consul-
tation, supervision, or direct care from the nodal centre.
To suit the needs of what has been construed by the
authors as ‘tele-enabling’ model, in contrast to the existing
‘tele-consultation’ models, a computerised diagnostic and
treatment application had to be constructed. For this
purpose, a logically linked computerised decision support
system for diagnosis and management of common psychi-
atric disorders in adults, and in children and adolescents,
has been developed as a part of this project. This internet-
based application is envisaged to enable non-specialists
accessing it at remote areas to independently provide care.
This requires 8 to 10 hours of training over two weeks,
conducted through video-conferencing by the nodal
centre. The software application has two separate decision
support systems one for adults, and one for children and
adolescents. In each case, the diagnostic system is logically
linked to the pharmacological and psychological interven-
tion modules taking into account the diagnosis, age, and
medical illnesses. All the components of the decision
system have been developed based on expert knowledge
and guidelines, clinical experience and expertise; and
utilize mainly ICD-10 [11] criteria.
For the diagnostic part of the application, the require-
ment was for a brief, but a comprehensive interview,
which would generate reliable diagnoses and be simple to
use. Two diagnostic interviews fulfilled these require-
ments; the well-validated Mini-International Neuropsychi-
atric Interview (MINI) [12], and a comparatively newer
computerized clinical assessment tool, the Global Mental
Health Assessment Tool – Primary Care Version (GMHAT-
PC) [13]. Both the MINI [12] and the GMHAT-PC
[13,14] take about 15 to16 minutes for each assessment,
while the time taken by other structured interviews
ranges from 45 to 180 minutes [12]. However, because
of copyright issues, none of these brief interviews could
be used. Moreover, both instruments did not includemany common disorders such as delirium, dementia,
adjustment, somatoform and dissociative disorders, neu-
rasthenia or sexual dysfunctions [12,13]. Therefore, it
was decided to develop an entirely new and indigenous
diagnostic tool, in keeping with the aims of the tele-
psychiatry project described earlier.
This paper describes the development of a new diag-
nostic system for this net-based application. Apart from
development, this initial pilot study also focuses on the
accuracy of diagnoses generated by the tool, in compari-
son to more detailed semi-structured clinical assessments
by teams led by consultant psychiatrists. Additionally,
preliminary data on feasibility of use of this new diagnostic
tool is also presented.
Methods
Basic approach and format of the diagnostic tool
The new net-based diagnostic tool was designed to
consist of a comprehensive psychiatric clinical interview,
albeit with a more focused and systematic approach. A
balance between an objective criteria-based diagnostic
exercise and conducting the interview in a conversa-
tional style was considered crucial, with the aim of repli-
cating the routine clinical interview situation, where
there is a greater need (as opposed to research settings)
to establish a therapeutic relationship with the patient
right from the onset of assessment. Moreover, the tool
was primarily intended for use by non-specialists (i.e.,
general physicians and para-professionals) in remote-
care settings. In keeping with these objectives, a struc-
tured format in simple language, easily understood by
both patients and interviewers was adopted. It was de-
cided that the diagnostic tool should cover both com-
mon and severe mental disorders. To meet the dual
objectives of a comprehensive screening and a focused
evaluation, a scheme of initial screening of patients for
all disorders included in the tool, followed by a detailed
assessment for specific disorders was incorporated. The
interview was also segregated into ‘core’ and ‘additional’
sections to reduce the time required for the entire diag-
nostic interview to about half an hour. Diagnoses were
based primarily on ICD 10 criteria, both from the Clinical
Diagnostic Guidelines [11] and the Diagnostic Criteria for
Research [15]. In certain parts (e.g. the diagnosis of deli-
rium or dementia), DSM IV [16] criteria were used.
The content and structure of the diagnostic tool
The diagnostic tool assesses for 18 disorders in adults,
namely, delirium, dementia, mania (current and past), de-
pression (current and past), dysthymia, psychosis, obses-
sive compulsive disorder, generalized anxiety disorder,
panic disorder, phobias, reaction to severe stress and adjust-
ment disorder, somatoform disorder, dissociative disorder,
neurasthenia, sexual dysfunctions, alcohol dependence,
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assesses for current symptoms, except for symptoms of
mood disorders, where both current and past symptoms
are elicited. To avoid multiple diagnoses, it includes a
diagnostic hierarchy by giving precedence to diagnostic
categories appearing first in the ICD10 manuals.
The diagnostic exercise follows a stepwise approach to
reach the final descriptive clinical diagnosis (see Figure 1).
Firstly, the identification details, socio-demographic pro-
file, presenting complaints and precipitating events are
elicited and recorded. This is followed by the ‘core’ diag-
nostic assessment, which includes initial screening for all
disorders, followed by detailed criteria-based questions for
specific disorders endorsed positive on screening. The
screening sub-module contains a total of 18 questions per-
taining to the 18 disorders, and acts as the first gateway to
the entire diagnostic exercise. Depending upon the posi-
tive responses on screening, the detailed diagnostic sub-
modules open in an order based on an inbuilt hierarchy.
In each diagnostic sub-module, there is a second-level en-
quiry about the primary or typical symptoms of that dis-
order, which proceeds with items pertaining to the other
criteria only if the specified threshold is met at the
second-level enquiry. Alternatively, it skips the remaining
part of that sub-module and moves to the next sub-
module as indicated in the first screening. This ‘core’ diag-
nostic assessment is sufficient to generate a psychiatric
diagnosis, but can be further supplemented by ‘additional’
sections on past, family, personal, developmental, medical
and treatment history details, and physical and mental status
examinations, whenever required. In addition, separate scales
have been developed to assess symptom severity (on a five-
point scale) and socio-occupational functioning (on a visual
analogue scale) at the end of diagnostic work-up.
The diagnostic algorithm for the screening and diag-
nostic sub-modules consists of three main components,
namely the question item with its serial number; the
‘rater’s rule’ for the rater to apply; and the ‘decision rule’
for computer automation (see Figure 2). Each question
item is based on the official classificatory systems, but is
more descriptive, uses culturally relevant idioms and
examples, and is simple to comprehend. For every ques-
tion item in the screening and diagnostic sub-modules, a
‘rater’s rule’ has been framed in a ‘yes/no’ format. The
rater’s rule specifies how the interviewer should rate an
item as present or absent, based on the intent of the
question, the duration and persistence of symptoms, and
the distress or dysfunction caused by the symptoms.
Thus, it incorporates a threshold for symptoms. For
example, in the sub-module for mania, the response to
the question about ‘feeling high or unusually happy’ is
considered positive only if the said behaviour ‘lasts for a
period of at least 4 days’, as mentioned in the ‘rater’s
rule’. There is also a provision for recording information,which is considered significant by the interviewer, but is
not captured in the categorical ‘yes/no’ format. The third
component, the ‘decision rule’ is an automated rule that
governs the flow of the diagnostic algorithm, as it de-
fines how this ‘yes’ or ‘no’ response will influence the
diagnostic decision tree. The ‘decision rules’ have been
built based on the diagnostic thresholds set by standard-
ized classification systems, as well as socio-cultural
norms, duration of symptoms, possibility of self-limiting
symptoms, and dysfunction caused by symptoms. The
‘decision rules’ also incorporate hierarchical rules for
skipping certain modules if a specific diagnosis is made,
even though those modules are indicated by the screen-
ing (for example, if a diagnosis of schizophrenia is made,
the module for anxiety disorders would not open, even if
indicated by screening).
Examining the diagnostic accuracy and feasibility of use
of the diagnostic tool
The diagnostic accuracy and feasibility of the tool was
examined for the English, as well as local language
(Hindi) versions of the diagnostic tool as applicable to
patients, at the department of psychiatry of PGIMER,
the nodal centre, after receiving approval from the ‘Insti-
tution Ethics Committee’ of Post-Graduate Institute of
Medical Education and Research (PGIMER), Chandigarh,
India. For this purpose, consecutive outpatients aged
more than 18 years, who gave written informed consent,
were assessed using the new diagnostic tool. Interviews
with the diagnostic tool were for the most part con-
ducted by four psychologists who had Master’s level
training in psychology, but had limited experience in
diagnosis and assessment of patients. They were all
trained by psychiatrists in the use of the diagnostic tool.
Patients were randomly allocated to undertake the tool-
based assessment followed by consultant’s evaluation, or
vice versa. Clinical assessments were undertaken in the
department by team of a trainee psychiatrist and a
consultant psychiatrist. These detailed semi-structured
assessments also used ICD10 diagnostic criteria and
generated ICD10 diagnoses. The interviewers using the
new diagnostic tool were blind to the consultant’s diag-
nosis, and the consultant psychiatrist was blind to the
diagnostic tool based assessment. Demographic data,
ratings on screening and diagnostic modules, diagnoses
generated by the tool and the consultants’ diagnoses
were all recorded. Additionally, details regarding the
completion rate, the total time taken, and feedback on
comprehensibility of language, style of questioning
and satisfaction, were also obtained from interviewers,
the patients and the relatives accompanying them.
The required sample size for kappa values of 0.4 to
0.6, at a power of 80% and alpha of 0.05, was esti-
mated to be 100.
Section G: Descriptive clinical 
diagnosis
Part XIV: Descriptive clinical 
diagnosis
Section B: Presenting Problems
Part III: Present Complaints
Part IV: Medical Illness Module 
Section C: Diagnostic Work Up
Part V: Screening Questionnaire for Adults 
Part VI: PGIMER Diagnostic Tool for 
Adults 
Section D: Background 
History
Each part is optional and can 
be independently 
administered
Part VII: Past Psychiatric 
History
Part VIII: Family History
Part IX: Personal History
Part X: Pre-morbid 
Personality
Section A: Registration
Part I: Identification Data of Patient
Part II: Details of the Informant
Section F: Functioning & Severity Assessment
Part XIII: Scale to rate symptom severity and 
Assessment of socio-occupational functioning scale               
Section E: Current 
Examination
Part XI: Physical Examination
Part XII: Mental Status 
Examination    
Figure 1 Flow of the diagnostic tool. The diagnostic exercise follows a stepwise approach to reach the final descriptive clinical diagnosis.
First, the identification details, socio-demographic profile, presenting complaints and precipitating events are elicited and recorded (Sections A
and B in the figure). This is followed by the ‘core’ diagnostic assessment (Section C in the figure), which includes initial screening for all disorders,
followed by detailed criteria-based questions for specific disorders endorsed positive on screening. This ‘core’ diagnostic assessment is sufficient
to generate a psychiatric diagnosis, but can be further supplemented by ‘additional’ sections on past, family, personal, developmental, medical
and treatment history details (Section D), and physical and mental status examinations (Section E), whenever required. In addition, separate scales
have been developed to assess symptom severity (on a five-point scale) and socio-occupational functioning (on a visual analogue scale) (Section F).
At the end of the diagnpostic work up, a descriptive clinical diagnosis is generated (Section G).
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S.No. Item Decision Rule
Q1 Has he been feeling so high or excited or unusually 
happy that he got into trouble with others or other people 
thought he was not his usual self?
For how long did it last?
Rate the item as Yes,  if  feeling high 
or excited or unusually happy for a 
period of at least 4 days                           
Yes/No
Go To Q 2
Q2 Has he been feeling so irritable that he had arguments or 
fights?
For how long did it last?
Rate the item as Yes,  if  feeling 
irritable for a period of at least 4 days
Yes/No
If Q1 or Q2 or Both
Are Yes  Go To Section B
If Q1 And Q2 Both
Are No  Go To Section E 
(Mania- Past)             
Figure 2 Sample of the software requirement specifications to build the core diagnostic support system. The core diagnostic support
system contains diagnostic algorithms for the screening and diagnostic sub-modules. These algorithms consist of three main components,
namely the question item with its serial number; the ‘rater’s rule’ for the rater to apply; and the ‘decision rule’ for computer automation. Each
question item is based on the official classificatory systems, but is more descriptive, uses culturally relevant idioms and examples, and is simple to
comprehend. For every question item in the screening and diagnostic sub-modules, a ‘rater’s rule’ has been framed in a ‘yes/no’ format. The
rater’s rule specifies how the interviewer should rate an item as present or absent, based on the intent of the question, the duration and persistence of
symptoms, and the distress or dysfunction caused by the symptoms. Thus, it incorporates a threshold for symptoms. The third component, the
‘decision rule’ is an automated rule that governs the flow of the diagnostic algorithm, as it defines how this ‘yes’ or ‘no’ response will influence the
diagnostic decision tree. The ‘decision rules’ have been built based on the diagnostic thresholds set by standardized classification systems, as well as
socio-cultural norms, duration of symptoms, possibility of self-limiting symptoms, and dysfunction caused by symptoms.
Table 1 Demographic details of participants (N = 100)
Variables Mean (SD) Frequency (%)




Gender Male 53 (53%)
Female 47 (47%)
Marital status Married 69 (69%)
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Statistical analysis was carried out using the Statistical
Package for Social Sciences-version fifteen [17]. Apart
from descriptive analyses, paired t-tests were conducted
to compare the mean number of diagnosis generated by
the two interviews. Analyses were carried out both for
the broad ICD 10 diagnostic categories, as well as some
individual categories belonging to mood and neurotic
disorders. Sensitivity, specificity, positive and negative
predictive values were computed for the screening and
the diagnostic sub-modules of the tool, compared to the
consultant’s diagnosis. Additionally, kappa coefficients
were computed to assess agreement between the diagno-
ses generated by the diagnostic sub-modules and the
consultant’s diagnosis.Single 26 (26%)
Others 5 (5%)







Over a period of 6 months a total of 107 persons were
included in the study; seven of these had to be excluded,
because a clear diagnosis could not be made after the
consultant’s evaluation. About half of these patients (n =
54) were assessed on the diagnostic tool first, while the
remaining patients underwent consultants’ evaluation
prior to assessment with the tool.Family Type Nuclear 47 (47%)
Joint 53 (53%)
Locality Rural 43 (43%)
Urban and semi-urban 57 (57%)Demographic profile of participants
Table 1 depicts the demographic profile of the 100 pa-
tients included in the study.Patients were middle-aged, with more men than women
constituting the study sample. They were mostly educated,
married, either employed or engaged in household work,
and mainly came from urban or semi-urban areas. This
corresponded to the usual profile of attendees at this
centre.
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The mean number of total diagnoses made by the diagnos-
tic sub-modules of the tool was 1.38 (SD 0.82), and that
made by the consultant’s evaluation was 1.23 (SD 0.48).
No significant difference was found between the mean
numbers of diagnoses between the two methods of assess-
ment. Organic disorders were diagnosed in 2% of the pa-
tients, alcohol use disorder in 4%, substance use disorders
in 6%, psychoses in 18%, mood disorders (bipolar disorder,Table 2 Frequency of diagnoses and agreement between diag
interview





Organic mental disorders 2 (2%) 5 (5%)
Alcohol dependence syndrome 4 (4%) 3 (3%)
Drug dependence syndrome 6 (6%) 4 (4%)
Psychotic disorders 18 (18%) 16 (16%)
Any Mood Disorder 47 (47%) 44 (44%)
Bipolar affective disorder 15 (15%) 14 (14%)
Manic episode 11 (11%) 7 (7%)
Depressive episode/Recurrent
depressive disorder
29 (29%) 25 (25%)
Dysthymia 6 (6%) 5 (5%)
Any Neurotic, Stress related &
Somatoform disorders
40 (40%) 39 (39%)
Anxiety (GAD, panic disorder, phobias)
and stress related disorders
17 (17%) 16 (16%)
OCD 11 (11%) 9 (9%)
Somatoform Disorders 17 (17%) 9 (9%)
Dissociative disorders 5 (5%) 6 (6%)
Sexual dysfunction 1 (1%) 2 (2%)
Mental Retardation 5 (5%) 7 (7%)major depression, dysthymia) in 47%, neurotic, stress
related and somatoform disorders in 40%, disorders of sex-
ual functioning in 1%, and mental retardation in 5% by the
diagnostic tool. No diagnosis could be reached by the tool
in four patients, and consultants’ diagnoses for these pa-
tients were somatoform disorder, anxiety disorder, organic
mood disorder and psychosis respectively. The frequencies
of diagnoses in each category made by the diagnostic tool
and by the consultant’s evaluation are included in Table 2.noses made by diagnostic sub-module and the clinical









2 0 0.56 0.4 1 1 0.97
3 95
3 1 0.85 1 0.99 0.75 1
0 93
3 3 0.58 0.75 0.97 0.5 0.99
1 93
13 5 0.72 0.81 0.94 0.72 0.96
3 79
36 11 0.62 0.82 0.80 0.77 0.85
8 45
10 5 0.64 0.71 0.94 0.67 0.95
4 81
6 5 0.64 0.86 0.95 0.55 0.99
1 88
18 11 0.54 0.72 0.85 0.62 0.90
7 64
1 5 0.14 0.2 0.95 0.16 0.96
4 90
31 9 0.64 0.80 0.85 0.78 0.87
8 52
9 8 0.46 0.56 0.90 0.53 0.92
7 76
9 2 0.89 1 0.98 0.82 1
0 89
8 9 0.56 0.89 0.90 0.47 0.99
1 82
3 2 0.52 0.50 0.98 0.6 0.97
3 92
1 0 0.66 0.5 1 1 0.99
1 98
5 0 0.82 0.71 1 1 0.98
2 93
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diagnoses
a. Screening sub-module of the diagnostic tool
Table 3 depicts the sensitivity, specificity, positive pre-
dictive value and negative predictive values of the
screening sub-module of the diagnostic tool, compared
to the diagnoses obtained following the consultant’s
evaluation.
The results show that the sensitivity of screening part
of the tool was high for most disorders except organic
brain disorders (60%) and sexual dysfunctions (50%).
This was because of the small number of patients in
these categories, and the high false negative rates ob-
tained in both these categories. The specificity of screen-
ing was also high for most of the disorders, apart from
the broad category of mood disorders (48%) and the
category of neurotic and stress-related disorders (28%),
where it was mainly compromised by low specificity of








Any Neurotic, Stress related & Somatoform disorders






Mental retardationstress-related disorders. In all these categories, low spe-
cificity appeared to result from the relatively low rates of
true negative cases. Positive predictive values were low
for almost all disorders, except mood disorder and men-
tal retardation. This was a reflection of the high rates of
false positive diagnoses in most categories. On the other
hand, negative predictive values were consistently high
because of the high rates of true negative cases in most
categories.
b. Diagnostic sub-modules of the diagnostic tool
Table 2 depicts the Cohen’s kappa values, sensitivity,
specificity, and positive and negative predictive values of
the diagnostic sub-modules of the tool, compared to
consultants’ diagnoses.
Cohen’ kappa values revealed substantial (>0.6) to near
perfect agreement for alcohol dependence, psychosis,
mood disorders (broad category), bipolar disorder, hypo-
mania/mania (current), unipolar and bipolar depressione values of screening sub-module of the diagnostic tool
Clinical interview
+ -







3 3 0.6 0.97 0.5 0.98
2 92
3 4 1 0.96 0.43 1
0 93
4 7 1 0.93 0.36 1
0 89
12 19 0.75 0.77 0.39 0.94
4 65
40 29 0.90 0.48 0.58 0.87
4 27
36 44 0.92 0.28 0.45 0.85
3 17
14 55 0.87 0.35 0.20 0.94
2 29
7 18 0.78 0.80 0.28 0.97
2 73
8 25 0.89 0.73 0.24 0.96
1 66
4 5 0.67 0.95 0.44 0.98
2 89
1 4 0.5 0.96 0.2 0.99
1 94
6 4 0.86 0.96 0.6 0.99
1 89
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ders, obsessive compulsive disorder, sexual dysfunction
and mental retardation. There moderate agreement (0.4 -
0.6) for organic disorders, drug dependence, anxiety and
stress-related disorders, and somatoform and dissociative
disorders. Low agreement was seen for dysthymia (0.14)
alone. Sensitivity of diagnoses was high, apart from dys-
thymia (20%), organic disorders (40%), generalized anxiety,
panic, phobic, and stress-related disorders (46%), sexual
dysfunctions (50%) dissociative disorders (52%) and soma-
toform disorders (54%). Low sensitivities were primarily
due to the high rates of false negative cases. Unlike the
screening section of the tool, specificity was high for all
the disorders, and positive predictive values were accept-
able to high for most disorders, except dysthymia (0.16)
and dissociative disorders (0.47). Thus, the numbers of
false positive diagnoses were reduced after applying the
diagnostic sub-modules. Similar to the screening sub-
module, negative predictive values were consistently, high
because of the high rates of true negative cases.
c. Discordance analysis
The number of discordant cases in each diagnostic cat-
egory is shown in Table 4. The maximum number of dis-
cordant cases was seen in mood disorders, and neurotic,
stress -related and somatoform disorders. Most of dis-
cordance between tool-based and clinical diagnoses was












Organic mental disorders 95 (95) 5 (5)
Alcohol dependence syndrome 99 (99) 1 (1)
Drug dependence syndrome 96 (96) 4 (4)
Psychotic disorders 92 (92) 8 (8)
Any Mood Disorder 77 (77) 23 (23)
BPAD 88 (88) 12 (12)
Depressive episode 83 (83) 17 (17)
Dysthymia 90 (90) 10 (10)
Any Neurotic, Stress related &
Somatoform disorders
81 (81) 19 (19)
Anxiety (GAD, panic disorder, phobias)
and stress related disorders
74 (74) 26 (26)
OCD 98 (98) 2 (2)
Somatoform Disorders 90 (90) 10 (10)
Dissociative disorders 96 (96) 4 (4)
Sexual dysfunction 99 (99) 1 (1)
Mental Retardation 98 (98) 2 (2)bipolar depression (current), and anxiety (generalized anx-
iety disorder, panic disorder, phobias) and stress-related
disorders. Eight discordant cases in the category of current
depression were diagnosed by consultants as having dys-
thymia or a neurotic disorder. Eleven out of 15 discordant
cases in the category of anxiety (generalized anxiety
disorder, panic disorder, phobias) and stress related dis-
orders were diagnosed by consultants as having another
neurotic and stress-related disorder or depression.
Duration of assessment using the new diagnostic tool
Details regarding the duration of assessment by the new
tool are shown in Table 5. The time taken for assess-
ment by the ‘core’ diagnostic tool was about 30 minutes,
and that for screening alone was about five minutes.
Feasibility of use of the new diagnostic tool
Results regarding feasibility of use are also are depicted
in Table 5.
All the participants completed the entire interview. A
majority of the patients, their relatives and the persons
conducting the assessment were satisfied with the inter-
view, especially with the language used and the style of
questioning, as well the extent to which the presenting
complaints were addressed by the interview.
Discussion
Assessing and detecting psychiatric disorders in general
health care settings, particularly in developing countries
like India, is a highly challenging task [18]. Several stra-
tegies including training of general health workers or
physicians have been proposed [18], and tried in the Na-
tional Mental Health Programme [5], but these strategies
have numerous problems such as inadequate training,
short-lived gains of the limited training received, lack of
motivation of personnel, and lack of support by psychia-
trists. It is, therefore, necessary to look for additional al-
ternatives, which do not rely on presence of psychiatrist
for every patient, and yet can deliver specialized care in
the most effective manner. The net-based tool for diag-
nosing and treating psychiatric disorders in adults devel-
oped as part of this project is envisaged to fulfil many of
these needs. The advantages of the tool are that: it is
based on standardized classificatory systems; it is struc-
tured, fully automated, with an in-built logical support
system for diagnosis management: it has facilities for real-
time and post-interview monitoring and support, when-
ever required. These features not only enhance the
performance of the tool, but also empower the interviewer
to carry out the process of diagnosis satisfactorily.
The primary focus of the current paper was to
describe the development of the tool, and present the pre-
liminary findings regarding the performance of the tool as
a screening and a diagnostic instrument, which would
Table 5 Results of the feasibility analysis of the diagnostic tool
Interviewee/informants Interviewer
Frequency N = 100 Frequency N = 100
Time taken for diagnostic assessment Mean - 30.69 (SD 10.87) minutes; Median - 29.5 minutes; Range: 10 – 60 minutes
Time taken for screening alone Mean - 4.85 (SD 0.86) minutes; Median - 5 minutes; Range: 3 – 8 minutes
Completion rate 100%
Overall satisfaction Very dissatisfied 0 0
Dissatisfied 9 14
Satisfied 57 66
Very satisfied 34 20
Comprehensibility of language Very difficult 0 0
Difficult 9 11
Easy 70 65
Very easy 21 24
Style of questioning Very difficult 1 6
Difficult 13 17
Easy 62 54
Very easy 24 23
Extent to which presenting complaints were addressed Very dissatisfied 2 4
Dissatisfied 8 10
Satisfied 65 58
Very satisfied 25 28
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Existing validated interviews such as the MINI could not
be used, mainly because of issues regarding copyright.
Therefore, an entirely new diagnostic tool had to be con-
structed. Being a pilot and proof-of-concept study of this
new diagnostic tool, certain limitations were inherent in
its design. Firstly, though the sample size was adequate
based on targeted kappa values, a much larger sample
would eventually be required to test the diagnostic ac-
curacy of the entire tool. The numbers involved for
many diagnostic categories were small. Therefore, the
agreement between diagnoses generated by the tool and
consultants’ diagnoses were tested for the broad catego-
ries in case of neurotic disorders, and not individual disor-
ders. Secondly, the comparison was carried out with
detailed semi-structured assessments made by a team
headed by a consultant psychiatrist. Ideally, another struc-
tured interview could have been used for comparison, as it
has been noted that reliability of open-form clinical inter-
views is comparatively low [19], though it can be improved
by using diagnostic criteria [20], as is the case in our
clinical setting. Other studies have also relied on consul-
tants’ diagnoses in the absence of a structured interview
comparison, or even otherwise [21,22]. Finally, at this
initial stage only a pre-computerised version of the
diagnostic tool could be tested. The aim was again to
gather as much data and experience with what was anentirely new diagnostic interview, before going in for
online activation and testing. The results of this study
need to be viewed in the light of these limitations.
Screening instruments for psychiatric disorders should
include commonly encountered disorders and have high
sensitivity for detection of these disorders, owing to their
disabling consequences [23]. The screening sub-module
of the diagnostic tool fulfilled both these criteria, as it
included a broad range of commonly prevalent disorders
and, with certain exceptions, had a high sensitivity for
detecting these disorders. Sensitivity was low for organic
disorders, because some of these were labelled as ‘func-
tional’ psychiatric disorders, a fallacy that has been com-
monly noted earlier [24]. Low sensitivity in case of
sexual dysfunctions was due to the inability to detect
one patient, presumably because of the sensitive nature
of the subject [25]. The specificity of screening was high
for most disorders as well, except for the broad category
of mood disorders and neurotic and stress-related
disorders, where it was mainly compromised by low spe-
cificity of the diagnoses of generalized anxiety, panic,
phobic and stress-related disorders. Low specificity of
screening instruments for the milder psychiatric
disorders, particularly anxiety disorders, is common with
other screening tools as well [26]. Positive predictive
values were also low for most disorders, which indicate a
high rate of false positive diagnoses. This is another
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tools [27,28]. However, a substantial number of patients
with false positive results meet diagnostic criteria for
other mental disorders, and the burden of follow-up
assessments for patients with positive screens is usually
not too high. Hence, it has been suggested that erring
on the side of sensitivity is preferable for instruments
screening for psychiatric disorders [29]. Finally, the con-
sistently high negative predictive values indicated that
the screening module was correctly identifying all those
without a psychiatric disorder who would not require
any further psychiatric intervention.
Although the mean number of diagnoses generated by
the diagnostic sub-modules of the tool was somewhat
higher than the clinical evaluation, this difference was
not significant. This finding was unlike that seen with
structured interviews; for example, the Composite Inter-
national Diagnostic Interview-Auto (CIDI-Auto) gene-
rates a mean number of 2.53 diagnoses per patient [30].
While this may be useful in research interviews, it
might present problems for routine clinical evaluation.
In this regard, the inbuilt hierarchies and exclusion rules
of the diagnostic tool reduced the chances of multiple
diagnoses, thereby simplifying the entire process for
the interviewer.
The kappa values indicated moderate (0.4-0.6) to high
(>0.6) agreement between the two assessments for all
disorders, except dysthymia. Moreover, sensitivity of the
detailed diagnostic sub-modules was high apart from
dysthymia, organic disorders, generalized anxiety, panic,
phobic and stress-related disorders, sexual dysfunctions,
and dissociative and somatoform disorders. Unlike the
screening module, specificity was high for all the dis-
orders and positive predictive values were acceptable to
high for most disorders, except dysthymia and dissocia-
tive disorders, while negative predictive values continued
to remain high for all disorders. Discordance analysis
revealed that for common mental disorders including
depression, dysthymia, and anxiety and stress-related
disorders, a large number of cases were classified inter-
changeably, which might explain the comparatively low
level of agreement seen with these disorders. Overall,
considering the kappa values, sensitivity and the pro-
portion of discordant diagnoses, the diagnostic tool
performed relatively poorly for the minor or common
mental disorders. Similarly, with other diagnostic inter-
views such as the NIMH-Diagnostic Interview Schedule
(DIS), the CIDI, or the MINI, agreement for dysthymia,
anxiety disorders and somatoform disorders has usually
been found to be lower when compared to clinical diag-
nosis, as clinicians regarded other diagnoses as domin-
ant, and did not diagnose anxiety disorders separately
though they agreed on the presence of symptoms
[12,22,31]. Nevertheless, these results suggested thatrefinement of diagnostic criteria were needed to improve
this aspect of the diagnostic tool.
Finally, the feasibility analysis demonstrated that the
instrument was easy to administer and was rated highly
both by the interviewer and the interviewee. In the new
tool a lot of emphasis has been placed on flexibility of
interviewing and establishing a therapeutic relationship
with the patient, without compromising on the objecti-
vity of assessment. The feasibility analysis suggested that
these features of the tool helped it recreate the clinical
situation to a large extent. All this was achieved in a
time of about 30 minutes, which was about a-third of
that required for detailed clinical evaluations. Only the
MINI [12] and the GMHAT/PC [14] take less time.
Moreover, the time taken for using the screening sub-
module was about five minutes, which was in keeping
with the suggestion that screening time should not be
more than about five minutes if an instrument is to be
widely adopted [12].
Therefore, despite some methodological limitations
and concerns about certain parts of the new diagnostic
tool, the findings of this preliminary study suggested that
it could prove suitable for use as a part of an online tele-
psychiatric application. Efforts are already underway to
further enhance the accuracy of the online version of the
diagnostic tool, to test its validity at the primary and se-
condary care levels with larger samples, and to validate
it against other structured interviews such as the MINI.
Conclusions
The development of a fully structured and automated
diagnostic system for adult psychiatric disorders is
described. Preliminary results suggested that despite
some limitations, diagnoses generated by the tool had an
acceptable level of accuracy, and the tool appeared to be
feasible to use. Therefore, it seemed to be suitable for
use as a part of an online telepsychiatric application
meant for diagnosis and management of adult psy-
chiatric disorders.
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